Article
04 Aug 2025
Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
31 Jul 2025
Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime
Article
20 Jun 2025
Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials
Article
05 Jun 2025
Patent Re-Examination Board Decision Does Not Preclude Patent Validity Challenge In Court
Article
12 Feb 2025
Federal Court Re-balances Due Care Assessment For Reinstating Abandoned Patent Applications
Article
23 Dec 2024
Novel Biosimilar Anti-Trust Complaint Involving Janssen's STELARA (Ustekinumab) Dismissed By The Canadian Competition Tribunal
Article
19 Dec 2024
Federal Court Of Appeal: Patented Medicine Prices Review Board "Crashed" Through "Guardrails" In Attempt To Regulate Unpatented Medicine
Article
04 Oct 2024
The Diaper Wars, Episode 2: FCA Finds US Parent Company Liable For Patent Infringement
Article
29 Aug 2024
JAMP Launches Novel Competition Complaint Alleging Janssen Abused Its Dominance Over Stelara (Ustekinumab)
Article
22 Aug 2022
Ontario Court Of Appeal Dismisses Apotex's Novel Patent Damages Appeal